The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
 
Abby B. Siegel
Research Funding - Astex Pharmaceuticals; Bayer/Onyx; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anthony B. El-Khoueiry
No Relationships to Disclose
 
Richard S. Finn
Consulting or Advisory Role - Bayer/Onyx
 
Katherine Guthrie
No Relationships to Disclose
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Roche
 
Charles David Blanke
Travel, Accommodations, Expenses - Novartis
 
Robert S. Brown
No Relationships to Disclose